Stock Price
28.20
Daily Change
-0.24 -0.84%
Monthly
3.15%
Yearly
10.59%
Q3 Forecast
28.26

Galapagos reported EUR780K in Interest Expense on Debt for its fiscal quarter ending in March of 2025.




Interest Expense On Debt Change Date
argenx SE USD 1.13M 9K Jun/2025
AstraZeneca USD 303M 126M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
Genmab DKK 9M 4M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline GBP 184M 22M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Hikma Pharmaceutical USD 22M 9M Jun/2024
Incyte USD 594K 66K Jun/2025
Merck EUR 79M 1000K Jun/2025
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Novartis USD 289M 19M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi EUR 148M 65M Jun/2025
UCB EUR 108M 16M Dec/2024
Vertex Pharmaceuticals USD 3.7M 900K Jun/2025